Atlas Trials

A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Clinical trial NCT06323356 · COMPLETED

Trial details

NCT number
NCT06323356
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Generalized Pustular PsoriasisErythrodermic Psoriasis
Start date
2024-03-19
Primary completion
2025-10-17
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.